臨床試驗

Efferon LPS Hemoadsorption in in Patients With Thermal Burns

NCT：NCT07568132 · NOT_YET_RECRUITING

NCT IDNCT07568132

狀態NOT_YET_RECRUITING

開始日期2026-05-15

完成時間2028-02-27

簡要摘要

The aim of the study is to evaluate the safety and efficacy of multimodal (cytokine and lipopolysaccharide) hemoadsorption using the Efferon® LPS device to reduce the severity of clinical symptoms and to prevent the progression of multiple organ dysfunction or to arrest its development in patients with burn disease with an RFI score ≥71 and ≤181. Patients will be randomized in two groups: control group receiving baseline therapy (including CRRT) and treatment group receiving baseline therapy and Efferon® LPS hemoadsorption in combination with CRRT.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。